Glioma Stem Cells-derived Exosomes Promote the Angiogenic Ability of Endothelial Cells Through MiR-21/VEGF Signal

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Apr 15

PMID 28410224

Citations 98

Authors

Xu Sun

Xiaotang Ma

Jinju Wang

Yuhui Zhao

Yue Wang

Ji C Bihl

Yanfang Chen

Chuanlu Jiang

Affiliations

Soon will be listed here.

Abstract

Glioma stem cells (GSCs) play an important role in glioblastoma prognosis. Exosomes (EXs) mediate cell communication by delivering microRNAs (miRs). Glioblastoma has a high level of miR-21 which could upregulate vascular endothelial growth factor (VEGF) expression. We hypothesized GSC-EXs can promote the angiogenic ability of endothelial cells (ECs) through miR-21/VEGF signal. GSCs were isolated from U-251 cells with stem cell marker CD133. GSCs transfected without or with scramble or miR-21 mimics were used to produce GSC-EXscon, GSC-EXssc and GSC-EXsmiR-21. Human brain ECs were co-cultured with vehicle, GSC-EXscon, GSC-EXssc or GSC-EXsmiR-21 plus VEGF siRNAs (siRNAVEGF). After 24 hours, the angiogenic abilities of ECs were evaluated. The levels of miR-21, VEGF and p-Flk1/VEGFR2 were determined. Results showed: 1) Over 90% of purified GSCs expressed CD133; 2) The levels of miR-21 and VEGF in GSCs and GSC-EXs were up-regulated by miR-21 mimic transfection; 3) Compared to GSC-EXscon or GSC-EXssc, GSC-EXsmiR-21 were more effective in elevating the levels of miR-21 and VEGF, and the ratio of p-Flk1/VEGFR2 in ECs; 4) GSC-EXsmiR-21 were more effective in promoting the angiogenic ability of ECs than GSC-EXscon or GSC-EXssc, which were remarkably reduced by siRNAVEGF pretreatment. In conclusion, GSC-EXs can promote the angiogenic ability of ECs by stimulating miR-21/VEGF/VEGFR2 signal pathway.

Citing Articles

Unlocking the therapeutic potential of tumor-derived EVs in ischemia-reperfusion: a breakthrough perspective from glioma and stroke.

Hao Z, Guan W, Wei W, Li M, Xiao Z, Sun Q J Neuroinflammation. 2025; 22(1):84.

PMID: 40089793 DOI: 10.1186/s12974-025-03405-7.

Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma.

Jin P, Bai X IBRO Neurosci Rep. 2025; 18:323-337.

PMID: 40034544 PMC: 11872630. DOI: 10.1016/j.ibneur.2025.01.015.

Critical roles of miR-21 in promotions angiogenesis: friend or foe?.

Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S Clin Exp Med. 2025; 25(1):66.

PMID: 39998742 PMC: 11861128. DOI: 10.1007/s10238-025-01600-7.

Impact of hypoxia on the molecular content of glioblastoma-derived exosomes.

Di Giulio S, Carata E, Muci M, Mariano S, Panzarini E Extracell Vesicles Circ Nucl Acids. 2024; 5(1):1-15.

PMID: 39698411 PMC: 11648508. DOI: 10.20517/evcna.2023.52.

Glioma-Derived Exosomes and Their Application as Drug Nanoparticles.

Mastantuono S, Manini I, Di Loreto C, Beltrami A, Vindigni M, Cesselli D Int J Mol Sci. 2024; 25(23).

PMID: 39684236 PMC: 11641060. DOI: 10.3390/ijms252312524.

References

Magee J, Piskounova E, Morrison S . Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012; 21(3):283-96. PMC: 4504432. DOI: 10.1016/j.ccr.2012.03.003. View

Chen T, Chen J, Wang X . Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood. Cell Prolif. 2006; 39(2):117-25. PMC: 6495845. DOI: 10.1111/j.1365-2184.2006.00375.x. View

Wang X, Gu H, Huang W, Peng J, Li Y, Yang L . Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice. Diabetes. 2016; 65(10):3111-28. PMC: 5033265. DOI: 10.2337/db15-1563. View

Dean M, Fojo T, Bates S . Tumour stem cells and drug resistance. Nat Rev Cancer. 2005; 5(4):275-84. DOI: 10.1038/nrc1590. View

Giusti I, Delle Monache S, Di Francesco M, Sanita P, DAscenzo S, Gravina G . From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis. Tumour Biol. 2016; 37(9):12743-12753. DOI: 10.1007/s13277-016-5165-0. View

Zeng H, Sanyal S, Mukhopadhyay D . Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J Biol Chem. 2001; 276(35):32714-9. DOI: 10.1074/jbc.M103130200. View

Fischer I, Gagner J, Law M, Newcomb E, Zagzag D . Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol. 2006; 15(4):297-310. PMC: 8096031. DOI: 10.1111/j.1750-3639.2005.tb00115.x. View

Sakurai T, Kudo M . Signaling pathways governing tumor angiogenesis. Oncology. 2012; 81 Suppl 1:24-9. DOI: 10.1159/000333256. View

Huang Z, Cheng L, Guryanova O, Wu Q, Bao S . Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting. Protein Cell. 2011; 1(7):638-55. PMC: 4875273. DOI: 10.1007/s13238-010-0078-y. View

10.

Mazzocca A, Coppari R, De Franco R, Cho J, Libermann T, Pinzani M . A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005; 65(11):4728-38. DOI: 10.1158/0008-5472.CAN-04-4449. View

11.

Clark P, Iida M, Treisman D, Kalluri H, Ezhilan S, Zorniak M . Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia. 2012; 14(5):420-8. PMC: 3384429. DOI: 10.1596/neo.12432. View

12.

Taraboletti G, DAscenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D . Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia. 2006; 8(2):96-103. PMC: 1578512. DOI: 10.1593/neo.05583. View

13.

Zachary I, Gliki G . Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 2001; 49(3):568-81. DOI: 10.1016/s0008-6363(00)00268-6. View

14.

Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki J . Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014; 124(25):3748-57. PMC: 4263983. DOI: 10.1182/blood-2014-05-576116. View

15.

Qin X, Yan L, Zhao X, Li C, Fu Y . microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett. 2012; 4(6):1290-1296. PMC: 3506726. DOI: 10.3892/ol.2012.896. View

16.

Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G . Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 2006; 13(7):1238-41. DOI: 10.1038/sj.cdd.4401872. View

17.

Shao Y, Shen Y, Chen T, Xu F, Chen X, Zheng S . The functions and clinical applications of tumor-derived exosomes. Oncotarget. 2016; 7(37):60736-60751. PMC: 5312416. DOI: 10.18632/oncotarget.11177. View

18.

Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H . MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007; 100(11):1579-88. DOI: 10.1161/CIRCRESAHA.106.141986. View

19.

Liu L, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y . MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression. PLoS One. 2011; 6(4):e19139. PMC: 3081346. DOI: 10.1371/journal.pone.0019139. View

20.

Shweiki D, Itin A, Soffer D, Keshet E . Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992; 359(6398):843-5. DOI: 10.1038/359843a0. View